Skip to content
Screener

EPS (Basic) at other companies

Bausch + Lomb logo
Bausch + LombBLCO
-$0.04+77.8%
Johnson & Johnson logo
Johnson & JohnsonJNJ
$2.300.0%
Staar Surgical logo
Staar SurgicalSTAA
$0.10+109%
Ardelyx logo
ArdelyxARDX
-$0.07+12.5%
Ironwood Pharmaceuticals logo
Ironwood PharmaceuticalsIRWD
$0.31+107%
AbbVie logo
AbbVieABBV
$0.39-45.8%

Other financials

Income statement

See full
Revenue$2.5B+11.7%
Operating income-$950.0M-444%
Net income-$1.4B-2,353%
EPS (diluted)-$3.82-2,287%

Balance sheet

See full
Cash & equivalents$1.3B+13.4%
Total debt$20.8B-3.5%
Total equity-$2.1B-74.0%
Total assets$24.5B-7.3%

Cash flow

See full
Operating cash flow$230.0M+9.0%
CapEx$109.0M-5.2%
Free cash flow$121.0M+26.0%

Valuation

See full
Market cap$2.21B+3.8%
Enterprise value$21.66B-2.1%
P/S0.2×0.0×

Profitability

See full
Gross margin71.4%
Operating margin5.6%-10.3pp
Net margin-1.9%-0.9pp
FCF margin9.8%-2.8pp

Returns & leverage

See full
Return on equity-70.1%
Debt / equity45.2×
Current ratio1.3×0.0×

Where this comes from

Reported directly by Bausch Health Companies in its filing.

Tagged under the XBRL concept us-gaap:EarningsPerShareBasic.

The source filing: Bausch Health Companies’s 10-Q, filed April 30, 2026.

Filed
Apr 29, 2026, 6:12 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0000885590-26-000053
Line itemThree Months Ended March 31, 2026Three Months Ended March 31, 2025
Foreign exchange and other(11)(4)
Loss before income taxes(1,354)(47)
Provision for income taxes(77)(39)
Net loss(1,431)(86)
Net loss attributable to noncontrolling interest828
Net loss attributable to Bausch Health Companies Inc.$(1,423)$(58)
Basic and diluted loss per share attributable to Bausch Health Companies Inc.$(3.82)$(0.16)
Basic and diluted weighted-average common shares372.8369.6

Item 1. Condensed Consolidated Financial Statements (unaudited)

FAQ

What is Bausch Health Companies's EPS (basic)?
Bausch Health Companies (BHC) reported EPS (basic) of -$3.82 in Q1 2026.
How has Bausch Health Companies's EPS (basic) changed year-over-year?
Bausch Health Companies's EPS (basic) decreased by 2287.5% year-over-year, from -$0.16 to -$3.82.
What is the long-term trend for Bausch Health Companies's EPS (basic)?
Over 2 years (2021 to 2023), Bausch Health Companies's EPS (basic) has grown at a -24.8% compound annual growth rate (CAGR), from -$2.85 to -$1.61.
What does EPS (basic) mean?
Net income available to common shareholders divided by the weighted-average number of common shares outstanding during the period. Does not account for dilutive securities.

Ask your AI about Bausch Health Companies's eps (basic).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude